Literature DB >> 12778465

Impaired contact hypersensitivity in macrophage migration inhibitory factor-deficient mice.

Tadamichi Shimizu1, Riichiro Abe, Jun Nishihira, Akihiko Shibaki, Hirokazu Watanabe, Toshinori Nakayama, Masaru Taniguchi, Teruo Ishibashi, Hiroshi Shimizu.   

Abstract

To determine whether macrophage migration inhibitory factor (MIF) is required for contact hypersensitivity (CHS) response, MIF-deficient (MIF KO) and wild-type (WT) mice were sensitized with trinitrochlorobenzene (TNCB) or oxazolone on their abdominal skin and challenged on the dorsum skin of one ear 5 days later. Significant ear swelling was observed in the WT mice, but this response was inhibited in the MIF KO mice (p<0.01 for MIF KO vs. WT mice in 24 h). In addition, lymph node cells from hapten-sensitized MIF KO mice showed a decreased capacity for transferring the CHS response. A topical application of TNCB (200 microg) caused a significant decline in epidermal Langerhans cell (LC) density (20.3%; p<0.01 compared with vehicle) 4 h after application in WT mice, but it failed to provoke a significant epidermal LC migration in MIF KO mice (7.4%). By mixed lymphocyte reaction, the T cell proliferative response to alloantigen was significantly decreased in the MIF KO mice compared with WT mice (p<0.005). Taken together, these results indicate that MIF is pivotal in the regulation of cutaneous immune responses and plays a central role in LC migration and T cell proliferation for the CHS response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12778465     DOI: 10.1002/eji.200323751

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Identification and expression of macrophage migration inhibitory factor in Sarcoptes scabiei.

Authors:  N M Cote; D C Jaworski; N B Wasala; M S Morgan; L G Arlian
Journal:  Exp Parasitol       Date:  2013-07-04       Impact factor: 2.011

2.  Role of macrophage migration inhibitory factor in the Th2 immune response to epicutaneous sensitization.

Authors:  Rituparna Das; Jeremy E Moss; Eve Robinson; Scott Roberts; Rebecca Levy; Yuka Mizue; Lin Leng; Courtney McDonald; Robert E Tigelaar; Christina A Herrick; Richard Bucala
Journal:  J Clin Immunol       Date:  2011-05-11       Impact factor: 8.317

3.  Neutralization of macrophage migration inhibitory factor (MIF) by fully human antibodies correlates with their specificity for the β-sheet structure of MIF.

Authors:  Randolf J Kerschbaumer; Manfred Rieger; Dirk Völkel; Didier Le Roy; Thierry Roger; Jurate Garbaraviciene; Wolf-Henning Boehncke; Jürgen Müllberg; Rene M Hoet; Clive R Wood; Gerhard Antoine; Michael Thiele; Helga Savidis-Dacho; Michael Dockal; Hartmut Ehrlich; Thierry Calandra; Friedrich Scheiflinger
Journal:  J Biol Chem       Date:  2012-01-11       Impact factor: 5.157

4.  Expression Patterns of Macrophage Migration Inhibitory Factor and Its Gene Variants (MIF-173 G˃C) in Verruca Vulgaris.

Authors:  Mohammed H Hassan; Sawsan Abuhamdah; Bakheet E M Elsadek; Ashraf Abdelwahab; Tarek Hamdy Abd-Elhamid; Hanan M Fayed; Amany Abbass; Ahmed Alamir Mahmoud Abdallah; Marwa Mohamed; Wafaa Mohamed Abd-Elmagid
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-06-10

5.  Metal allergy and systemic contact dermatitis: an overview.

Authors:  Yoko Yoshihisa; Tadamichi Shimizu
Journal:  Dermatol Res Pract       Date:  2012-05-30

6.  The Fate of a Hapten - From the Skin to Modification of Macrophage Migration Inhibitory Factor (MIF) in Lymph Nodes.

Authors:  Isabella Karlsson; Kristin Samuelsson; Carl Simonsson; Anna-Lena Stenfeldt; Ulrika Nilsson; Leopold L Ilag; Charlotte Jonsson; Ann-Therese Karlberg
Journal:  Sci Rep       Date:  2018-02-13       Impact factor: 4.379

7.  Haptenation of Macrophage Migration Inhibitory Factor: A Potential Biomarker for Contact Hypersensitivity.

Authors:  Lorena Ndreu; Samantha Sasse; Ann-Therese Karlberg; Isabella Karlsson
Journal:  Front Toxicol       Date:  2022-04-06

8.  Macrophage migration inhibitory factor as an incriminating agent in dermatological disorders.

Authors:  Nader Pazyar; Amir Feily; Reza Yaghoobi
Journal:  Indian J Dermatol       Date:  2013-03       Impact factor: 1.494

9.  Macrophage migration inhibitory factor protects from nonmelanoma epidermal tumors by regulating the number of antigen-presenting cells in skin.

Authors:  Tania Brocks; Oleg Fedorchenko; Nicola Schliermann; Astrid Stein; Ute M Moll; Seth Seegobin; Manfred Dewor; Michael Hallek; Yvonne Marquardt; Katharina Fietkau; Ruth Heise; Sebastian Huth; Herbert Pfister; Juergen Bernhagen; Richard Bucala; Jens M Baron; Guenter Fingerle-Rowson
Journal:  FASEB J       Date:  2016-10-19       Impact factor: 5.834

10.  MMP19 is essential for T cell development and T cell-mediated cutaneous immune responses.

Authors:  Inken M Beck; René Rückert; Katja Brandt; Markus S Mueller; Thorsten Sadowski; Rena Brauer; Peter Schirmacher; Rolf Mentlein; Radislav Sedlacek
Journal:  PLoS One       Date:  2008-06-04       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.